About IAC
A-Z Index
Immunization Action Coalition
IAC Home
News & Information
Official Releases

Official Releases

Advisory Committee on Immunization Practices

Use of Vaccinia Virus Smallpox Vaccine in Laboratory and Health Care Personnel at Risk for Occupational Exposure to Orthopoxviruses
ACIP Recommendations - 3/18/16
2016 U.S. Recommended Immunization Schedules for Persons Aged 0 Through 18 Years
2016 U.S. Recommended Immunization Schedule for Adults Aged 19 Years or Older
Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults
ACIP recommendations - 10/23/15
Updated intervals between PCV13 and PPSV23 vaccines for use in immunocompetent adults age 65 years and older
ACIP recommendations - 9/4/15
Guidance for the use of Quadracel (DTaP+IPV combination vaccine) as a booster dose
ACIP recommendations - 9/4/15
Prevention and Control of Influenza with Vaccines (2015–16)
ACIP recommendations - 8/7/15
Yellow Fever Vaccine Booster Doses
ACIP recommendations - 6/19/15
Use of Serogroup B Meningococcal Vaccines in Persons Aged >10 Years at Increased Risk for Serogroup B Meningococcal Disease
ACIP recommendations - 6/12/15
Use of 9-Valent Human Papillomavirus (HPV) Vaccine
ACIP recommendations - 3/26/15
Updated Typhoid Vaccination Recommendations
ACIP recommendations - 3/26/15
Official Releases
News & Information Home
View All
- AAP: American Academy of Pediatrics
- ACIP: Advisory Committee on Immunization Practices
- CDC: Centers for Disease Control and Prevention
- FDA: Food and Drug Administration
Additional ACIP Information
ACIP - Chronological
ACIP - Vaccine Index
ACIP - Topics of Interest
Vaccine Policy & Licensure
About ACIP
Description of the committee, includes goals, responsibilities, as well as contact information
This page was updated on March 31, 2016.
This page was reviewed on March 31, 2016.
Immunization Action Coalition  •  2550 University Avenue West  •  Suite 415 North  •  Saint Paul, Minnesota  •  55114
tel 651-647-9009  •  fax 651-647-9131
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000589) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.